AB Science was founded in by a team of researchers, clinicians and entrepreneurs who have dedicated their lives to discover key mechanisms in life science and develop new drugs targeting these mechanisms to dramatically change the life of patients in the most unmet medical needs. We are innovators and scientific entrepreneurs in the field of life science.
Quote | Ab Science Paris Ord (OTCMKTS:ABSCF)
Last: | $2.70 |
---|---|
Change Percent: | 0.0% |
Open: | $2.7 |
Close: | $2.70 |
High: | $2.7 |
Low: | $2.7 |
Volume: | 1,452 |
Last Trade Date Time: | 03/27/2024 03:00:00 am |
News | Ab Science Paris Ord (OTCMKTS:ABSCF)
PRESS RELEASE NEW RESEARCH SHOWS THAT MASITINIB LIMITS NEURONAL DAMAGE IN A MODEL OF NEUROIMMUNE-DRIVEN NEURODEGENERATIVE DISEASE THIS IS THE FIRST DEMONSTRATION THAT MASITINIB CAN LOWER SERUM NEUROFILAMENT LIGHT CHAIN, AN IMPORTANT BIOMARKER FOR NEURODEGENERATIVE DISORDERS ...
PRESS RELEASE SUMMARY OF THE WEBCAST HELD ON MARCH 4, 2024 PROVIDING AN UPDATE ON AB SCIENCE DEVELOPMENT Paris, March 7, 2024, 3pm CET AB Science SA (Euronext - FR0010557264 - AB) is providing a summary of the live webcast held on March 4, 2024, giving an update on AB Sc...
Message Board Posts | Ab Science Paris Ord (OTCMKTS:ABSCF)
Subject | By | Source | When |
---|---|---|---|
Stock_Tracker: Latest Ab Science Paris (ABSCF) Headlines AB Science: initiation of a new phase 3 stu | Stock_Tracker | investorshangout | 03/08/2014 9:34:50 PM |
chartguy89: ABSCF 19.62 Stock Charts $ABSCF 1 Month Chart | chartguy89 | investorshangout | 03/05/2014 10:56:04 PM |
Stock_Tracker: ABSCF Recent News AB Science: initiation of a new phase 3 study with masitinib in Pro | Stock_Tracker | investorshangout | 03/02/2014 4:23:40 AM |
chartguy89: ABSCF Stock Charts Saturday, February 22, 2014 at 12:18:40 AM $ABSCF Last: +0.92 | chartguy89 | investorshangout | 02/22/2014 5:18:51 AM |
chartguy89: ABSCF Stock Chart 19.62 Saturday, February 8, 2014 00:19:39 AM | chartguy89 | investorshangout | 02/08/2014 5:19:45 AM |
News, Short Squeeze, Breakout and More Instantly...
Ab Science Paris Ord Company Name:
ABSCF Stock Symbol:
OTCMKTS Market:
PRESS RELEASE NEW RESEARCH SHOWS THAT MASITINIB LIMITS NEURONAL DAMAGE IN A MODEL OF NEUROIMMUNE-DRIVEN NEURODEGENERATIVE DISEASE THIS IS THE FIRST DEMONSTRATION THAT MASITINIB CAN LOWER SERUM NEUROFILAMENT LIGHT CHAIN, AN IMPORTANT BIOMARKER FOR NEURODEGENERATIVE DISORDERS ...
PRESS RELEASE SUMMARY OF THE WEBCAST HELD ON MARCH 4, 2024 PROVIDING AN UPDATE ON AB SCIENCE DEVELOPMENT Paris, March 7, 2024, 3pm CET AB Science SA (Euronext - FR0010557264 - AB) is providing a summary of the live webcast held on March 4, 2024, giving an update on AB Sc...
PRESS RELEASE TWO NEW FINANCIAL ANALYSIS FIRMS INITIATE COVERAGE OF AB SCIENCE Paris, March 6, 2024, 8.15pm CET AB Science SA (Euronext - FR0010557264 - AB) announces that two financial analysis firms, DNA Finance and In Extenso Finance, have initiated the coverage of th...